Purchases and Sales Made in Q3 2024 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q3 2024. The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-184K- 32.58% |
$4.4M - $5.77M
|
381K
$11.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-193K- 26.89% |
$4.61M - $6.04M
|
524K
$15.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-204K- 84.5% |
$4.89M - $6.39M
|
37.5K
$1.09M
|
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-212K- 83.84% |
$5.07M - $6.63M
|
40.9K
$1.19M
|
|
|
Oct 23, 2024
Q3 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-223K- 90.22% |
$5.33M - $6.97M
|
24.1K
$702K
|
|
|
Nov 12, 2024
Q3 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-231K- 21.24% |
$5.53M - $7.24M
|
857K
$24.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-246K- 10.71% |
$5.88M - $7.7M
|
2.05M
$59.7M
|
|
|
Nov 12, 2024
Q3 2024
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-252K- 95.75% |
$6.03M - $7.9M
|
11.2K
$326K
|
|
|
Nov 14, 2024
Q3 2024
|
Twinbeech Capital LP
Purchase, NY |
SELL
|
- |
-263K- 77.2% |
$6.3M - $8.25M
|
77.8K
$2.26M
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-346K- 85.22% |
$8.27M - $10.8M
|
60K
$1.74M
|
|
|
Nov 14, 2024
Q3 2024
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-367K- 26.37% |
$8.77M - $11.5M
|
1.02M
$29.8M
|
|
|
Nov 14, 2024
Q3 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-495K- 11.27% |
$11.8M - $15.5M
|
3.89M
$113M
|
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.4M- 95.27% |
$33.5M - $43.8M
|
69.6K
$2.02M
|
|
|
Nov 14, 2024
Q3 2024
|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
SELL
|
- |
-5.8M- 18.67% |
$139M - $182M
|
25.3M
$735M
|